Sequential intravesical gemcitabine and docetaxel versus bacillus Calmette-Guerin for the treatment of high-risk, treatment-naive, non-muscle invasive bladder cancer.

被引:0
|
作者
McElree, Ian M.
Steinberg, Ryan L.
Mott, Sarah L.
O'Donnell, Michael A.
Packiam, Vignesh T.
机构
[1] Univ Iowa, Carver Coll Med, Iowa City, IA USA
[2] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[3] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
497
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG
    Steinberg, Ryan L.
    Packiam, Vignesh T.
    Thomas, Lewis J.
    Brooks, Nathan
    Vitale, Andrew
    Mott, Sarah L.
    Crump, Trafford
    Wang, Jonathan
    DeWolf, William C.
    Lamm, Donald L.
    Kates, Max
    Hyndman, M. Eric
    Kamat, Ashish M.
    Bivalacqua, Trinity J.
    Nepple, Kenneth G.
    O'Donnell, Michael A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (01) : 9.e1 - 9.e7
  • [32] Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer
    Shepherd, Andrew R. H.
    Shepherd, Emily
    Brook, Nicholas R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [33] Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status
    Liu, Gang
    Li, Bingheng
    Xu, Ziyang
    Wang, Jie
    Ma, Sai
    Kan, Yi
    Mao, Lijun
    DISCOVERY MEDICINE, 2022, 33 (169) : 85 - 92
  • [34] THE BURDEN OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER AMONG PATIENTS TREATED WITH BACILLUS CALMETTE-GUERIN
    Kopenhafer, L.
    Chang, J.
    Thompson, A.
    Sikirica, S.
    Masters, E. T.
    Cappelleri, J. C.
    Peck, E. Y.
    Maculaitis, M. C.
    VALUE IN HEALTH, 2022, 25 (07) : S557 - S557
  • [35] Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin Drug Shortage
    Chun, Brian
    He, Meiqi
    Jones, Cameron
    Vasan, Robin
    Gabriel, Nico
    Jacobs, Bruce L.
    Hernandez, Inmaculada
    Davies, Benjamin J.
    UROLOGY, 2023, 177 : 74 - 80
  • [36] Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
    James, Christopher
    Gomez, Kayeromi
    Desai, Shalin
    Patel, Hiten D.
    Rac, Goran
    Doshi, Chirag P.
    Dornbier, Ryan
    Bajic, Petar
    Halverson, Thomas
    Gupta, Gopal N.
    Quek, Marcus L.
    Gorbonos, Alex
    Flanigan, Robert
    Wolfe, Alan J.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [37] Single nucleotide polymorphisms as markers of bacillus Calmette-Guerin intravesical therapy response in non-muscle invasive bladder cancer.
    Alanee, Shaheen
    Hamilton, Robert James
    Joseph, Vijai
    Ostrovnaya, Irina
    Garcia-Grossman, Ilana Rebecca
    Gallagher, David J.
    Pendse, Deepa
    Regazzi, Ashley Marie
    Przybylo, Jennifer A.
    Gaudet, Mia
    Milowsky, Matthew I.
    Herr, Harry W.
    Offit, Kenneth
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] CARCINOGENESIS AND BACILLUS CALMETTE-GUERIN (BCG) INTRAVESICAL TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER UNDER TRYPTOPHAN AND THYMINE SUPPLEMENTATION
    Ossick, Marina
    Kiehl, Isis
    Salustiano, Ana Clara
    Ferrari, Karen
    Degasperi, Giovanna
    Linarelli, Maria
    Reis, Leonardo
    JOURNAL OF UROLOGY, 2021, 206 : E1133 - E1133
  • [39] Evaluation of sarcopenia in patients receiving intravesical Bacillus Calmette-Guerin for non-muscle invasive bladder cancer
    Alam, Syed M.
    Larson, Matthew
    Srinivasan, Pugazhendhi
    Genz, Nick
    Fleer, Ryan
    Sardiu, Mihaela
    Thompson, Jeffrey
    Lee, Eugene
    Hamilton-Reeves, Jill
    Wulff-Burchfield, Elizabeth
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (10) : 431.e15 - 431.e20
  • [40] Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Bree, K. K.
    Hensley, P. J.
    Brooks, N.
    Matulay, J.
    Navai, N.
    Grossman, H. B.
    Matin, S. F.
    Dinney, C. P.
    Kamat, A. M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 898 - 898